Home
Scholarly Works
Efficacy and Safety of Benralizumab Compared with...
Conference

Efficacy and Safety of Benralizumab Compared with Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis in Patients Receiving Standard of Care Therapy: Phase 3 MANDARA Study

Authors

Wechsler M; Nair P; Terrier B; Walz B; Bourdin A; Jayne D; Jackson D; Roufosse F; Sjo LB; Fan Y

Volume

75

Pagination

pp. 5222-5225

Publisher

WILEY

Publication Date

October 1, 2023

Conference proceedings

ARTHRITIS & RHEUMATOLOGY

ISSN

2326-5191

Contact the Experts team